Adam Zamecnik is a healthcare reporter at Pharmaceutical Technology. He covers a range of topics including pharmaceutical manufacturing, regulation, and consumer health, with a particular focus on new technologies, health inequality, and cell and gene therapy research. Adam's work has been featured in Pharmaceutical Technology and Citeline.
Preston's Summary
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Geo Focus
Coverage Attributes:
Beta
Press Release:
33
%
Government Announcement:
33
%
Private Sector Announcements:
33
%
Themes Covered:
Not enough data
Pitching Insights
Adam Zamecnik's coverage primarily focuses on the healthcare and pharmaceutical industry, with specific emphasis on medical research, cancer treatment, clinical trials, muscle wasting syndrome, and Actimed. His articles often include event coverage and press releases.
To effectively reach out to Adam Zamecnik, consider offering insights or interviews related to groundbreaking medical research in areas such as gene therapies for diseases like sickle cell disease. Additionally, experts who can provide valuable perspectives on navigating oncology trials or addressing challenges in drug development within the pharmaceutical landscape may capture his interest.
Given Zamecnik's focus on Europe 2023 events and EU guidelines affecting clinical work, individuals knowledgeable about regulatory changes impacting drug development in these regions could also be compelling sources for him.
This information evolves through artificial intelligence and human feedback. Improve this profile .
